• Français
  • Search
  • Conference
    • CAHR 2023
    • Future CAHR Conferences
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • Become a Member
    • CAHR Annual General Meeting
    • CAHR Strategic Plan 2020 – 2025
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media
    • Featured Researchers
  • Conference
    • CAHR 2023
    • Future CAHR Conferences
    • Sponsors & Exhibitors
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • CAHR Board Trainee
    • Become a Member
    • CAHR Strategic Plan 2020 – 2025
    • CAHR Annual General Meeting
    • Call for Nominations: CAHR Board of Directors
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media

CAHR Conference Co-Chairs

 

A major focus of Dr Jérôme Estaquier research program has been dedicated to study the mechanisms programmed cell death (PCD) in which apoptosis is one of the major phenotypes. His research interests are to analyze these mechanisms in the context of host-pathogen interaction. Indeed, early cell death contribute to immunodeficiency favoring viral dissemination and pathogenesis. Furthermore, the consequence and how the infected cells are dying are of crucial importance favoring either tolerance or inflammatory responses. Thus, the specificity of his research aimed at clarifying the biochemical and molecular mechanisms, in particular the role of mitochondria, and downstream research studying these mechanisms in vivo by using Non-Human Primates (NHP). These models give him the opportunity to test new vaccines and drug therapeutic approaches.

Thus, Dr Estaquier is an internationally known immunologist with interest in physiopathology of microbe infections in NHP models. He published more than 165 original publications and reviews. He was recruited in 1996 as an associated professor at Institut National de la Santé et de la Recherche Médicale (INSERM, France) after several years at Institut Pasteur Lille (France), La Jolla Institute for Allergy and Immunology (LIAI, USA) and Centre international de recherches médicales de Franceville (CIRMF, Gabon). He joined Laval University in 2011 in the context of the Canadian Research Chair (CRC) program. Dr Estaquier contributed to various scientific committees like French National committees (CNRS and INSERM) and the National Agency for AIDS Research (ANRS) as well for different Canadian Institutions such as Canadian Institutes of Health Research (CIHR).  At Laval University, a new platform for NHP models dedicated to microbe infections was created in 2011. This structure supports Canadian researchers such as in the context of the Canadian HIV Cure Enterprise (CanCURE).

 

Dr Cecilia Costiniuk is an Associate Professor in the Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service at the McGill University Health Centre, and a clinician-scientist at the Research Institute of the McGill University Health Centre in Montreal, Canada.  Her research program focuses on pulmonary immune disturbances in people living with HIV and the immunomodulatory effects of cannabinoids on HIV-associated inflammation.  During the COVID-19 pandemic, she has been leading the Canadian HIV Trials Network (CTN) 328 study on COVID-19 vaccine immunogenicity in people living with HIV (COVAXHIV), which prospectively follows nearly 400 people living with HIV in Canada, with a focus on individuals frequently underrepresented in clinical research.  Her research also examines cannabinoids and cannabinoid-based medicine as a strategy to reduce chronic inflammation in people living with HIV.  In addition to her work with COVAXHIV, Dr Costiniuk co-leads the CTN Vaccines and Immunotherapy Core.  Dr Costiniuk is also a member of the Canadian HIV Cure Enterprise (CanCURE), a research collaboratory focused on studying HIV persistence during antiretroviral therapy and developing strategies towards a sustainable HIV remission. Dr Costiniuk was a 2022 recipient of the Canadian Association for HIV Research – Canadian Foundation for AIDS Research (CAHR-CANFAR) Excellence in HIV Research Award in recognition of her track record of excellence and her demonstrated commitment to improving the lives of those living with, or at risk for, HIV.

 

Conference Menu

  • CAHR 2023
  • Important Dates
  • Abstract Submission
  • Registration
  • Venue & Travel
  • Program
  • CAHR Conference Co-Chairs
  • Scientific Committee
  • Sponsors & Exhibitors
  • Ancillary Event Requests
  • Conference Code of Conduct
  • Scholarships & Awards
  • Conference Secretariat

Our Mission

  • Promote excellence in HIV research
  • Foster collaboration and cooperation among HIV research communities, including basic science, clinical science, epidemiology & public health and social science
  • Promote education and the development of new researchers
  • Provide a unified voice for Canadian HIV researchers and engage diverse stakeholders (community, industry, Government, NGO’s etc.) in ongoing dialogue and knowledge exchange to ensure that HIV research remains responsive to their needs
CAHR 2023 Conference Logo

CAHR 2023
April 27 to 30, 2023

Learn More

Recent News

  • Last day to apply for the CAHR-@CANFAR Excellence in Research Awards! cahr-acrv.ca/awards/excelle… Dernier jour pour postuler aux Bourses d'excellence en recherche CAHR-@CANFAR! cahr-acrv.ca/fr/prix/prix-d… https://t.co/szhBdhZuRZ
  • Remember to apply for the CAHR-RV-@CAN Excellence in Research Awards by January 26th! cahr-acrv.ca/awards/excelle… Après le 26 janvier nous n’acceptons plus de candidatures aux Prix d'excellence en recherche ACRV-RV-@CAN! cahr-acrv.ca/fr/prix/prix-d… https://t.co/bhgkCEDBmD
  • Reminder: Apply Now – A workshop on “Jumpstarting your Participatory Social-Behavioural Health Intervention” cahr-acrv.ca/wp-content/upl… UmnUV @CBRC weets @CAT EInfo @Giving_
  • Rappel : Postulez maintenant - Un atelier sur « Lancez votre intervention participative en santé sociocomportementale ». cahr-acrv.ca/wp-content/upl… ZS @CBRCtwe ts @CATIEI fo @Giving_It_
  • Looking to attend #CROI2023? Find out if you qualify for a travel award! Applications are due by end of day on January 22, 2023. cahr-acrv.ca/awards/hcp-tra… #HIVCan @ias_usa
  • Se souvenir de Chris Bunting
Subscribe to the CAHR Newsletter

About CAHR

With a membership of more than 1,000 researchers and others interested in HIV research, the Canadian Association for HIV Research (CAHR) is the leading organization of HIV/AIDS researchers in Canada. CAHR is the organizing body for the Annual Canadian Conference on HIV/AIDS Research (CAHR Conference).

CAHR encourages Canadian researchers to be leaders in knowledge translation and to effectively respond both to the Canadian and global HIV/AIDS epidemics. Since its founding in 1991, CAHR has promoted excellence in HIV research, including mentorship and career development of investigators entering the field.

CAHR fosters collaboration and co-operation among HIV research communities, including basic, clinical and social sciences, epidemiology and public health. CAHR also engages people living with HIV/AIDS and AIDS service organizations in ongoing dialogue and information exchange to ensure that HIV/AIDS research remains responsive to the epidemic and its stakeholders.

CAHR is a registered charity.

Links

  • Who We Are
  • Conference
  • Awards
  • Workshops
  • Featured Researchers
  • Student Profiles
  • CAHR News

Contact

For more information or to make a comment, please contact us:

Canadian Association for HIV Research

440 Laurier Avenue West, Suite 200
Ottawa, Ontario K1R 7X6

1-888-374-CAHR (2247)
info@cahr-acrv.ca
  • Media
  • Contact
  • Français